SIRT1 – a new mammalian substrate of nuclear autophagy

Lu Wang,Caiyue Xu,Terje Johansen,Shelley L. Berger,Zhixun Dou
DOI: https://doi.org/10.1080/15548627.2020.1860541
IF: 13.391
2020-12-20
Autophagy
Abstract:<span>Macroautophagic/autophagic degradation of nuclear components (or nuclear autophagy) is a poorly understood area in autophagy research. We previously reported the nuclear lamina protein LMNB1 (lamin B1) as a nuclear autophagy substrate in primary human cells, stimulating the investigation of nuclear autophagy in the mammalian system. We recently reported the sirtuin protein SIRT1 as a new selective substrate of nuclear autophagy in senescence and aging. Upon senescence of primary human cells, SIRT1 degradation is mediated by a direct nuclear SIRT1-LC3 interaction, followed by nucleus-to-cytoplasm shuttling of SIRT1 and autophagosome-lysosome degradation. In vivo, SIRT1 is downregulated by lysosomes in hematopoietic and immune organs upon natural aging in mice and in aged human T cells. Our study identified another substrate of nuclear autophagy and suggests a new strategy to promote SIRT1-mediated health benefits by suppressing its autophagic degradation. <b>Abbreviations:</b> HSPC: hematopoietic stem and progenitor cells; NAD<sup>+</sup>: nicotinamide adenine dinucleotide; SASP: senescence-associated secretory phenotype</span>
cell biology
What problem does this paper attempt to address?
The paper attempts to address the role of cellular autophagy (specifically nucleophagy) in the aging process and the specific role of the SIRT1 protein in this process. Specifically: 1. **SIRT1 as a new substrate for nucleophagy**: The paper reports for the first time that the SIRT1 protein is degraded through the nucleophagy pathway during cellular aging. SIRT1 is an important deacetylase involved in regulating metabolism and the aging process. The study found that during cellular aging, SIRT1 directly interacts with the LC3 protein, subsequently translocates from the nucleus to the cytoplasm, and is eventually degraded by the autophagosome-lysosome system. 2. **Changes in SIRT1 during natural aging**: The study also explored the changes in the SIRT1 protein during natural aging. Experimental results showed that in certain tissues of mice (such as the testes, spleen, thymus, etc.) and in CD8+ CD28- T cells of elderly donors, the levels of SIRT1 protein significantly decreased, while its mRNA levels remained unchanged. This indicates that the reduction of SIRT1 protein is achieved through the lysosomal degradation pathway. 3. **Biological significance of nucleophagy in aging**: The paper further discusses the biological significance of nucleophagy in cellular aging. Nucleophagy not only promotes cell cycle arrest but also stimulates the production of the senescence-associated secretory phenotype (SASP), which helps the immune system clear senescent cells, thereby inhibiting tumorigenesis. However, prolonged nucleophagy and cellular senescence may impair tissue renewal capacity, promote chronic inflammation, and contribute to age-related diseases. In summary, the paper aims to reveal the new mechanism of SIRT1 as a substrate for nucleophagy in cellular and natural aging processes and to explore the potential application value of these findings in delaying aging and treating age-related diseases.